CLINICAL_TRIALS
trial_result
· 2025-05-22
Clinical Trial Update: A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment [Phase 3]
Summary
A Phase 3 study assessing efficacy and safety of ASP1941 in patients with type 2 diabetes and renal impairment has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED